Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA Fusion PET/MRI for Prostate Biopsies
NCT03689582Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Nov 2018
- Primary completion
- Feb 2020
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by University of Michigan Rogel Cancer Center. Started Nov 2018; status: terminated.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03689582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689582.